| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Erasca, Inc. (ERAS) has 11 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. ERAS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.00M | $20.46M | - | |
| CFO | 640.0K | $6.55M | - | |
| Dir | 120.0K | $1.23M | - | |
| Dir | 96.0K | $982.1K | - | |
| Dir | 37.8K | $386.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 | Garner Ebun | General Counsel | Buy | 900 | $16.00 | $14,400.00 | New | -11.7% | -59.0% | |
| Jul 20, 2021 | Start Valerie Denise Harding | Director | Buy | 2,000 | $16.00 | $32,000.00 | New | -11.7% | -59.0% | |
| Jul 20, 2021 | Hambleton Julie | Director | Buy | 6,000 | $16.00 | $96,000.00 | New | -11.7% | -59.0% | |
| Jul 20, 2021 | Multani Pratik S | Director | Buy | 6,200 | $16.00 | $99,200.00 | +3.7% | -11.7% | -59.0% |